Sandra J van Vliet Selected Research

Sandra J van Vliet Research Topics

Disease

40	Neoplasms (Cancer) 04/2024 - 08/2007
8	Colorectal Neoplasms (Colorectal Cancer) 08/2020 - 08/2007
6	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2018
5	Adenocarcinoma 04/2024 - 08/2007
4	Infections 01/2022 - 03/2002
4	Inflammation (Inflammations) 01/2021 - 03/2013
3	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 01/2021
3	Melanoma (Melanoma, Malignant) 01/2020 - 01/2019
3	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2020 - 08/2007
2	Pathologic Processes 01/2019 - 01/2019
2	Multiple Sclerosis 07/2015 - 03/2013
2	Immune System Diseases (Immune Disorders) 07/2015 - 03/2002
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Disease Progression 11/2022
1	Glioma (Gliomas) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Neuroinflammatory Diseases 06/2019
1	Lymphatic Metastasis 01/2019
1	Adenosquamous Carcinoma 01/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Leukemia 01/2019
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Microsatellite Instability 09/2015
1	Colonic Neoplasms (Colon Cancer) 09/2015
1	Hypoxia (Hypoxemia) 08/2015
1	Crohn Disease (Crohn's Disease) 03/2013
1	Cholangiocarcinoma 01/2012
1	Aspergillosis 11/2011

Drug/Important Bio-Agent (IBA)

21	Polysaccharides (Glycans)IBA 04/2024 - 08/2007
15	AntigensIBA 01/2023 - 06/2003
11	LigandsIBA 04/2024 - 03/2014
10	C-Type Lectins (C-Type Lectin)IBA 08/2020 - 08/2007
9	Galactose (Galactopyranose)FDA LinkGeneric 10/2021 - 08/2007
8	Tn antigenIBA 01/2023 - 08/2007
8	LectinsIBA 10/2021 - 08/2007
5	N-Acetylneuraminic Acid (Sialic Acid)IBA 04/2024 - 07/2016
5	CarbohydratesIBA 10/2022 - 07/2011
5	Glycoproteins (Glycoprotein)IBA 08/2020 - 01/2012
4	Sialic AcidsIBA 04/2024 - 01/2019
4	EpitopesIBA 01/2021 - 01/2018
4	CytokinesIBA 01/2021 - 08/2007
4	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 01/2019 - 03/2002
3	Sialic Acid Binding Immunoglobulin-like LectinsIBA 04/2024 - 01/2018
3	Mucin-1 (CA 15-3 Antigen)IBA 01/2023 - 08/2007
3	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2019
3	Pattern Recognition ReceptorsIBA 01/2020 - 08/2007
2	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2018
2	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2019
2	GangliosidesIBA 01/2023 - 07/2011
2	GlycoconjugatesIBA 01/2023 - 01/2022
2	VaccinesIBA 01/2022 - 07/2016
2	Interleukin-10 (Interleukin 10)IBA 10/2021 - 01/2021
2	Peptides (Polypeptides)IBA 06/2021 - 01/2020
2	AcetylgalactosamineIBA 11/2019 - 01/2018
2	FucosyltransferasesIBA 01/2019 - 01/2018
2	Mannose (D-Mannose)IBA 01/2019 - 01/2016
2	EnzymesIBA 01/2019 - 01/2019
1	RNA (Ribonucleic Acid)IBA 03/2024
1	GlycopeptidesIBA 01/2023
1	AntibodiesIBA 01/2023
1	MucinsIBA 01/2023
1	GalactosamineIBA 10/2022
1	Serine (L-Serine)FDA Link 10/2022
1	Threonine (L-Threonine)FDA Link 10/2022
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 01/2022
1	Lipid Bilayers (Lipid Bilayer)IBA 06/2021
1	Palmitic Acid (Hexadecanoic Acid)IBA 06/2021
1	Histocompatibility Antigens Class IIBA 06/2021
1	Interleukin-12 (IL 12)IBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	ProteomeIBA 08/2020
1	GlycosphingolipidsIBA 01/2020
1	MannosidesIBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Toll-Like Receptor 7IBA 01/2019
1	sialosyl-Tn antigenIBA 01/2019
1	Conjugate VaccinesIBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Lewis Blood Group AntigensIBA 01/2018
1	TransferasesIBA 01/2018
1	FucoseIBA 01/2018
1	Neuraminidase (Sialidase)IBA 07/2016
1	Neoplasm Antigens (Tumor Antigens)IBA 07/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	villinIBA 01/2016
1	Mannose ReceptorIBA 07/2015
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2014
1	Bile Acids and Salts (Bile Acids)IBA 01/2012
1	Chenodeoxycholic Acid (Chenix)FDA Link 01/2012
1	Taurine FDA Link 01/2012
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2012
1	galactosaminogalactanIBA 11/2011

Therapy/Procedure

9	Immunotherapy 04/2024 - 07/2016
4	Therapeutics 01/2021 - 03/2013
3	Drug Therapy (Chemotherapy) 01/2019 - 01/2018
1	Adjuvant Chemotherapy 09/2015
1	Immunomodulation 07/2015